References
- Godley LA, Shimamura A. Genetic predisposition to hematologic malignancies: management and surveillance. Blood. 2017;130(4):424–432. doi:https://doi.org/10.1182/blood-2017-02-735290.
- Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127(20):2391–2405. doi:https://doi.org/10.1182/blood-2016-03-643544.
- Hahn CN, Chong CE, Carmichael CL, et al. Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia. Nat Genet. 2011;43(10):1012–1017. doi:https://doi.org/10.1038/ng.913.
- Rodrigues NP, Janzen V, Forkert R, et al. Haploinsufficiency of GATA-2 perturbs adult hematopoietic stem-cell homeostasis. Blood. 2005;106(2):477–484. doi:https://doi.org/10.1182/blood-2004-08-2989.
- Ling KW, Ottersbach K, Van Hamburg JP, et al. GATA-2 plays two functionally distinct roles during the ontogeny of hematopoietic stem cells. J Exp Med. 2004;200(7):871–882. doi:https://doi.org/10.1084/jem.20031556.
- Wlodarski MW, Hirabayashi S, Pastor V, et al. Prevalence, clinical characteristics, and prognosis of GATA2-related myelodysplastic syndromes in children and adolescents. Blood. 2016;127(11):1387–1397. doi:https://doi.org/10.1182/blood-2015-09-669937.
- Cavalcante de Andrade Silva M, Katsumura KR, Mehta C, Velloso EDRP, Bresnick EH, Godley LA. Breaking the spatial constraint between neighboring zinc fingers: a new germline mutation in GATA2 deficiency syndrome. Leukemia. 2021;35(1):264–268. doi:https://doi.org/10.1038/s41375-020-0820-2.
- Hsu AP, Sampaio EP, Khan J, et al. Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome. Blood. 2011;118(10):2653–2655. doi:https://doi.org/10.1182/blood-2011-05-356352.
- Ostergaard P, Simpson MA, Connell FC, et al. Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome). Nat Genet. 2011;43(10):929–931. doi:https://doi.org/10.1038/ng.923.
- Scott HS, Hahn CN, Carmichael CL, et al. GATA2 is a new predisposition gene for familial myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). Blood. 2010;116(21):LBA-3–LBA-3. doi:https://doi.org/10.1182/blood.V116.21.LBA-3.LBA-3.
- Spinner MA, Sanchez LA, Hsu AP, et al. GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity. Blood. 2014;123(6):809–821. doi:https://doi.org/10.1182/blood-2013-07-515528.
- Hong YC, Liu HM, Chen PS, et al. Hair follicle: a reliable source of recipient origin after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2007;40(9):871–874. doi:https://doi.org/10.1038/sj.bmt.1705823.
- Locatelli F, Strahm B. How I treat myelodysplastic syndromes of childhood. Blood. 2018;131(13):1406–1414. doi:https://doi.org/10.1182/blood-2017-09-765214.
- Galera P, Hsu AP, Wang W, et al. Donor-derived MDS/AML in families with germline GATA2 mutation. Blood. 2018;132(18):1994–1998. doi:https://doi.org/10.1182/blood-2018-07-861070.
- Hofmann I, Avagyan S, Stetson A, et al. Comparison of outcomes of myeloablative allogeneic stem cell transplantation for pediatric patients with bone marrow failure, myelodysplastic syndrome and acute myeloid leukemia with and without germline GATA2 mutations. Biol Blood Marrow Transplant. 2020;26(6):1124–1130. doi:https://doi.org/10.1016/j.bbmt.2020.02.015.
- Bortnick R, Wlodarski M, de Haas V, et al. Hematopoietic stem cell transplantation in children and adolescents with GATA2-related myelodysplastic syndrome. Bone Marrow Transplant. 2021:1–10. doi:https://doi.org/10.1038/s41409-021-01374-y.
- Bruzzese A, Leardini D, Masetti R, et al. Gata2 related conditions and predisposition to pediatric myelodysplastic syndromes. Cancers (Basel). 2020;12(10):2962. doi:https://doi.org/10.3390/cancers12102962.